IRadimed Corp reports results for the quarter ended December 31 - Earnings Summary

IRADIMED

13/02/2025 14:31

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted
earnings of
44 cents​​ per share for the quarter ended December 31, higher
than the same quarter last year, when the company reported EPS
of 39 cents.  The mean expectation of two analysts for the
quarter was for earnings of 44 cents per share. Wall Street
expected results to range from 43 cents to 45 cents per share.
    * Revenue rose 11.1% to $19.39 million from a year ago;
analysts
expected $19.14 million. 
    * IRadimed Corp's reported EPS for the quarter was 40
cents​.
    * The company reported quarterly net income of $5.15
million.
    * IRadimed Corp shares had risen by 10.0% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for IRadimed Corp is
$65.00 
This summary was machine generated from LSEG data February 13 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.44           0.44           Met
 Sep. 30 2024      0.39           0.43           Beat
 Jun. 30 2024      0.37           0.42           Beat
 Mar. 31 2024      0.34           0.36           Beat